Centerpoint Advisors’s GSK GSK Stock Holding History

Centerpoint Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-152	Closed	-$7K	–	424
2025 Q3	$7K	Buy	+152	New	+$5.94K	﹤0.01%	348
2024 Q3	–	Sell	-392	Closed	-$15K	–	476
2024 Q2	$15K	Hold	392	–	–	0.01%	311
2024 Q1	$17K	Hold	392	–	–	0.01%	277
2023 Q4	$15K	Sell	392 -454	-54%	-$16.3K	0.01%	294
2023 Q3	$31K	Hold	846	–	–	0.01%	184
2023 Q2	$30K	Hold	846	–	–	0.01%	202
2023 Q1	$30K	Buy	846 +454	+116%	+$15.9K	0.01%	209
2022 Q4	$14K	Hold	392	–	–	0.01%	261
2022 Q3	$12K	Hold	392	–	–	0.01%	208
2022 Q2	$21K	Hold	392	–	–	0.01%	186
2022 Q1	$21K	Hold	392	–	–	0.01%	190
2021 Q4	$22K	Buy	+392	New	+$20.4K	0.01%	177
2018 Q3	–	Sell	-579	Closed	-$29K	–	291
2018 Q2	$29K	Buy	+579	New	+$29.2K	0.02%	123

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Acadian Asset Management

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Royal Bank of Canada

Royal Bank of Canada Toronto, Ontario, Canada $528B AUM 27.57% 1-Year Est. Return

Holocene Advisors

Holocene Advisors New York $41.3B AUM 42.97% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return